会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • APTAMER INHIBITION OF THROMBUS FORMATION
    • APTAMER对血栓形成的抑制作用
    • WO2010019847A3
    • 2010-05-14
    • PCT/US2009053825
    • 2009-08-14
    • UNIV GEORGIA STATE RES FOUNDWANG BINGHELI MINYONGNI NANTINGLIU YIDAN
    • WANG BINGHELI MINYONGNI NANTINGLIU YIDAN
    • A61K48/00A61K31/7088A61K38/36A61P7/02C07H21/00
    • C12N15/115A61K31/7088C12N2310/16
    • Boronic acid-modified DNA-based aptamers can be selected to recognize fibrinogen through binding at a glycosylation site and thus are useful for probing the effect of glycosylation pattern changes on the ability for fibrinogen to mediate blood coagulation. In addition, the aptamers of the disclosure also have anticoagulation effects due to their binding to fibrinogen and its cleavage product fibrin. The present disclosure, therefore, encompasses methods for inhibiting fibrin coagulation with an aptamer capable of specifically binding to a glycosylation site of fibrinogen or fibrin. The disclosure further provides oligonucleotide aptamers comprising at least one nucleotide having a boronic acid thereon, where the aptamer is capable of selectively binding to a glycosylation site of fibrinogen, or the derivative thereof.
    • 可以选择硼酸修饰的基于DNA的适体通过在糖基化位点结合来识别纤维蛋白原,因此可用于探测糖基化模式改变对纤维蛋白原介导血液凝固的能力的影响。 此外,本公开的适体由于其与纤维蛋白原及其裂解产物纤维蛋白的结合而具有抗凝作用。 因此,本公开内容包括用能够特异性结合纤维蛋白原或纤维蛋白的糖基化位点的适体抑制纤维蛋白凝固的方法。 本公开还提供了包含至少一个在其上具有硼酸的核苷酸的寡核苷酸适体,其中适体能够选择性地结合纤维蛋白原或其衍生物的糖基化位点。